Recently, using SAGE (Serial Analysis of Gene Expression) technology, St. Croix et al, have identified 46 genes, whose expression is specifically elevated in tumor-associated endothelium. Nine of these genes were prominently expressed only in tumor endothelial cells (EC), but were absent or barely detectable in normal ECs, and named as Tumor Endothelial Markers (TEMs, TEM 1-9). TEM7 (Tumor endothelial marker 7) transcripts are specifically expressed in the endothelium of colorectal cancer, primary cancers of lung, pancreas, breast, and brain. TEM7 is expressed specifically in endothelium of these cancers, whether primary or metastasis. The other six members of this family (TEM1, 3, 4, 5, 8, and 9) also show similar expression pattern in lung and brain tumors, and liver metastasis. Since most of the genes expressed differentially in tumor endothelium are also expressed during angiogenesis, these newly discovered genes might provide important resources for basic and clinical studies of human angiogenesis.

Long Name

Tumor Endothelial Marker 7/Plexin Domain Containing Protein 1

Alternate Names

PLXDC1, TEM3

Gene Symbol

PLXDC1

Additional TEM7/PLXDC1 Products

Product Documents for TEM7/PLXDC1 Antibody [PerCP]

Product Datasheets

Download Product Datasheets

COA

SDS

Download SDS

Product Specific Notices for TEM7/PLXDC1 Antibody [PerCP]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations
Reviews

TEM7/PLXDC1 Antibody [PerCP]

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-99868PCP

Key Product Details

Species Reactivity

Applications

Label

Antibody Source

Concentration

View all TEM7/PLXDC1 Antibodies »

Product Specifications

Immunogen

Clonality

Host

Isotype

Applications for TEM7/PLXDC1 Antibody [PerCP]

ELISA

Formulation, Preparation, and Storage

Purification

Formulation

Preservative

Concentration

Shipping

Stability & Storage

Background: TEM7/PLXDC1